NLRC3 and colorectal carcinoma: A combined analysis of TCGA (http://cancergenome.nih.gov) and Oncomine (https://www.oncomine.org) datasets, with mRNA expression analysis of tissue samples, revealed that NOD1 and NOD2 expression is usually increased, while NLRC3 and NLRC4 expression is reduced in CRC [148].